MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 - Germany

This page is part of the MII IG Kerndatensatz-Modul Onkologie (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Example Observation: Verlauf - 6 Monate nach FOLFOX

English

status: Final

code: Status of regression of tumor (observable entity)

subject: Hans Schmidt Male, DoB: 1959-03-15 ( https://www.medizininformatik-initiative.de/fhir/sid/patienten#FOLFOX-2024-001)

focus: Condition Bösartige Neubildung: Colon sigmoideum

effective: 2025-03-15

value: Vollremission (complete remission, CR)

note:

Patient completed 12 cycles of adjuvant FOLFOX4. CT scan and colonoscopy show no evidence of recurrence. CEA level normal (2.1 ng/mL). Patient is disease-free at 6-month follow-up. Plan: Continue surveillance with CEA and imaging every 3-6 months.

component

code: Status of residual neoplasm (observable entity)

value: Kein Tumor nachweisbar

component

code: Presence of metastatic neoplasm in regional lymph node (observable entity)

value: kein Lymphknotenbefall nachweisbar

component

code: Status of distant metastasis (observable entity)

value: Keine Fernmetastasen nachweisbar